Key result
Reimbursement policy revision linked to ~3% rise in remote monitoring, driven by pacemaker patients.
Why the study?
Does a reimbursement revision increase the proportion of remote monitoring adoption in patients with cardiac implantable electronic devices?
Observational (n=396,296)
Yes
Does a reimbursement revision increase the proportion of remote monitoring adoption in patients with cardiac implantable electronic devices?
Reimbursement policy changes significantly increased remote monitoring adoption for pacemaker patients, but not for ICD/CRT patients, highlighting differential impacts of financial incentives by device type.
Reimbursement revision was associated with modest remote monitoring gains, mainly in pacemakers; leaves open differential device effects and outcome impact.
BACKGROUND: Remote monitoring (RM) enables early detection of abnormalities in cardiac implantable electronic devices (CIED), but implementation remains suboptimal. METHODS AND RESULTS: We analyzed 396,296 patients hospitalized for CIED implantation and evaluated changes after RM reimbursement revision using an interrupted time-series analysis. The proportion increased by 4.89% (95% confidence interval [CI]: 3.71 to 6.06%) in the pacemaker implantation cohort, but no significant increase was observed in the implantable cardioverter defibrillator and cardiac resynchronization therapy cohort (0.79%; 95% CI: -1.12 to 2.71%). CONCLUSIONS: The effect of reimbursement policy changes on RM adoption may differ according to the type of CIED.
No takes yet. Share an insight, caveat, or question.
Takegawa et al. (2026) conducted an observational in Cardiac implantable electronic device (CIED) implantation (n=396,296). Reimbursement revision for remote monitoring vs. Before reimbursement revision was evaluated on Change in the proportion of patients receiving remote monitoring per month (level change 2.97%, 95% CI 1.91 to 4.04, p=<0.001). The reimbursement policy revision was associated with a 2.97% overall increase in the proportion of remote monitoring, driven by a 4.89% increase in the pacemaker cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: